Guru Ownership Trend
Guru Analysis for Apellis Pharmaceuticals, Inc. (APLS)
Apellis Pharmaceuticals, Inc. (APLS), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $163.27 M.
Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $44.28 M net outflow during the quarter.
Recent activity highlights Steven Cohen who increased their stake by 175.3%. Conversely, Jefferies Group reduced exposure by 96.5%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Apellis Pharmaceuticals, Inc. (APLS)
Major holders include Cliff Asness ($57.19 M), Renaissance Technologies (RenTech) ($15.9 M), Steven Cohen ($15.01 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 4.04 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $44.28 M, with 4 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 0 fully exited APLS. The total reported sell value was $63.89 M.
Yes, 2 managers opened new positions in APLS, and 2 increased their existing holdings. The total reported buy value was $19.61 M.
